Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -884.81% is 361% below its 5-year average of -191.79%, around the middle of its 5-year range (-1756.52%–-62.79%).
30.48% below its 12-month average of -678.10%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -347.87%.
EBITDA MARGIN
-884.81%
EBITDA MARGIN AVG TTM
-678.10%
EBITDA MARGIN AVG 3Y
-242.66%
EBITDA MARGIN AVG 5Y
-191.79%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-30.48%
CURRENT VS 3Y AVG
-264.63%
CURRENT VS 5Y AVG
-361.34%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Scilex Holding Company
Market Cap
$33.58M
EBITDA Margin
-884.81%
TTM Avg
-678.10%
3Y Avg
-242.66%
5Y Avg
-191.79%
Market Cap
$33.60M
EBITDA Margin
-3982.39%
TTM Avg
-3087.93%
3Y Avg
-1849.71%
5Y Avg
-2051.20%
Market Cap
$33.12M
EBITDA Margin
-6.58%
TTM Avg
-1.77%
3Y Avg
-0.14%
5Y Avg
1.64%
Market Cap
$34.48M
EBITDA Margin
-127.12%
TTM Avg
-129.61%
3Y Avg
-125.08%
5Y Avg
-93.97%
Market Cap
$34.50M
EBITDA Margin
-7905.63%
TTM Avg
-7905.63%
3Y Avg
-7905.63%
5Y Avg
-7905.63%
Market Cap
$32.17M
EBITDA Margin
-3.61%
TTM Avg
-0.43%
3Y Avg
-7.34%
5Y Avg
-19.38%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scilex Holding Company (SCLX) | $33.58M | -884.81% | -678.10% | -242.66% | -191.79% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.60M | -3982.39% | -3087.93% | -1849.71% | -2051.20% |
| Accuray Incorporated (ARAY)vs › | $33.12M | -6.58% | -1.77% | -0.14% | 1.64% |
| HeartBeam, Inc. (BEAT)vs › | $33.71M | 31.08% | 27.03% | 24.58% | 21.46% |
| Elutia Inc (ELUT)vs › | $34.48M | -127.12% | -129.61% | -125.08% | -93.97% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | -7905.63% | -7905.63% | -7905.63% | -7905.63% |
| Rockwell Medical, Inc. (RMTI)vs › | $32.17M | -3.61% | -0.43% | -7.34% | -19.38% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.19M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.57M | -22.81% | -7.79% | -0.80% | -0.97% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.14% | 1.67% | 3.35% | 2.87% |
Gross Margin
49.7%
EBITDA Margin
-884.8%
Operating Margin
-903.5%
Net Margin
-1414.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -347.87% |
| 2026-03-31 | -340.18% |
| 2025-12-31 | -748.88% |
| 2025-09-30 | -1756.52% |
| 2025-06-30 | -197.02% |
| 2025-03-31 | -537.47% |
| 2024-12-31 | -183.72% |
| 2024-09-30 | -131.01% |
| 2024-06-30 | -89.30% |
| 2024-03-31 | -169.49% |
| 2023-12-31 | -128.55% |
| 2023-09-30 | -371.57% |
| 2023-06-30 | -173.09% |
| 2023-03-31 | -230.92% |
| 2022-12-31 | -156.94% |
| 2022-09-30 | -84.20% |
| 2022-06-30 | -132.79% |
| 2022-03-31 | -115.41% |
| 2021-12-31 | -114.61% |
| 2021-09-30 | -77.12% |
| 2021-06-30 | -62.79% |
| 2021-03-31 | -188.24% |
| 2020-12-31 | -133.79% |
| 2020-09-30 | -133.79% |
| 2020-06-30 | -133.79% |
| 2020-03-31 | -133.79% |
| 2019-12-31 | -641.76% |
| 2019-09-30 | -641.76% |
| 2019-06-30 | -641.76% |
| 2019-03-31 | -641.76% |
